|
Docrates Cancer Center is the first and currently the only private hospital in the Nordic Countries that comprehensively specialises in cancer treatment. It operates in Helsinki, Finland. It characterises its operations as those complementing the public sector. Docrates Oy was established in 2006 and the hospital started its operations at the premises of Eira Hospital in autumn 2007. It moved to its own premises in Jätkäsaari, Helsinki, in 2009, where it has hospital rights. The ward and laboratory of Eira Hospital are in connection with Docrates Cancer Center. Among other things, diagnostics, pharmacotherapy, radiation therapy and isotopic treatments are carried out at the hospital. Cancer surgeries are performed in other hospitals. Docrates also participates in clinical trials and the testing and development of new treatments. The property of Docrates at Saukonpaadenranta is a part of the regional building project of Länsisatama in Jätkäsaari. The hospital's co-operation partners also work there. == Founders, ownership basis and business economics == Docrates Oy was established in 2006 by physicist Pekka Aalto, doctor Timo Joensuu and physicist Harri Puurunen. Pekka Aalto (born 1945) has participated in the development of the targeted radiotherapy that saves tissue, and acted as an entrepreneur and business manager in the field of radiotherapy technology. Timo Joensuu, Associate Professor of Medical Oncology (born 1959), has as a doctor and a researcher specialised in cancer drugs as well as radiotherapy and isotopic treatments. He has acted as the Chief Clinical Director of Docrates hospital for years. Starting from March 2014, Specialist in Medical Oncology and Radiotherapy, Associate Professor Tom Wiklund has acted as the Chief Clinical Director of the hospital. Harri Puurunen (born 1959) has as a physicist participated in the projects of Dosetek, directed by Aalto, and worked with corporate financing in the public sector and as the Director of Technology of Tekes. Puurunen was the Managing Director of Docrates during 2006 and 2010 and during 2011 and 2012 and thereafter the CFO. During 2010 and 2011, the Managing Director was Marco Hautalahti. In 2012, Siv Schalin was appointed as the Managing Director. She was the Managing Director of GE Healthcare Finland and is still a board member of Outokumpu Plc. The regular staff of doctors of the hospital include: Kalevi Kairemo, Chief Physician of Molecular Radiotherapy & Nuclear Medicine; Tuomo Alanko, Chief Physician of Medical Oncology; Martti Ala-Opas, Chief Urologist; Kaarina Partanen, Chief Radiologist; and Leila Vaalavirta, Chief Oncologist of Radiotherapy. Akseli Hemminki, an academic researcher who develops oncolytic virus treatments, has been involved in the operations of the clinic from the very beginning.〔(PI Akseli Hemminki | FIMM )〕〔(Helsinki University Bulletin )〕〔http://www.hi.helsinki.fi/cgtg/downloads/Guse_Vaccinia%20Virus%20review_EOBT_2011.pdf〕 A group of private individuals became shareholders of Docrates Oy and, in 2008, Helsingin Lääkärikeskus, currently Aava Terveyspalvelut Oy, became the largest owner. The turnover of the hospital was EUR 11 million in 2013 (EUR 9 million in 2012, EUR 6 million in 2010, EUR 3 million in 2009). During the early years, the company was unprofitable but the result has improved as turnover has increased. The number of employees has increased to approximately 40 persons by 2014, excluding indirectly employed researchers and doctors.〔(Docrates Sairaala - taloustiedot - Fonecta Finder )〕〔http://www.hel2.fi/helakanslia/Kaupunginhallitus/Esityslistat/liitteet/071450300.pdf〕〔(Docrates Oy - Docrates )〕 The number of patient visits was 16,000 per year. A fifth of all patients were from abroad. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Docrates Cancer Center」の詳細全文を読む スポンサード リンク
|